Genesis Consortium’s cover photo
Genesis Consortium

Genesis Consortium

Biotechnology Research

Investing in the future of human and planetary health. Founded by SOSV IndieBio & Mayfield.

About us

The Genesis Consortium is setting up to enable a greater range of VCs and corporates to be more active in investing in the future of human and planetary health. Those committed to life science investing are invited to join founding members SOSV IndieBio and Mayfield Capital in creating the Genesis Consortium. Post-COVID, the Genesis Consortium will put together monthly, quarterly, and annual physical events in life sciences investing, with a dinner series focused on relevant and emerging topics of life science breakthroughs; with tech talks and seminars on a frequent basis both at the IndieBio event center in San Francisco and a new IndieBio center opening in New York; and with an annual corporate engagement conference for later stage investors and corporates.

Industry
Biotechnology Research
Company size
51-200 employees
Founded
2020

Affiliated pages

Similar pages